Search

Issue
Title
Authors
Analysis of socio-demographic and clinical-morphological characteristics of recurrent and metastatic cervical cancer
Orlova R.V., Gorkina Y.R., Protasova A.E., Molchanov S.V., Krotov M.Y.
Oxaliplatin-induced peripheral neuropathy as a factor influencing the efficacy of the mFOLFOX6 regimen in patients with metastatic colorectal cancer: a retrospective study
Natalenko S.A., Orlova R.V., Belyak N.P., Kutukova S.I., Ksanaeva L.A.
Evaluation of the efficacy of pembrolizumab in patients with metastatic cervical cancer depending on the value of the neutrophil-lymphocyte index
Orlova R.V., Gorkina Y.R.
The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Semiglazov V.F., Krivorotko P.V., Komyakhov A.V., Semiglazova T.Y., Gigolaeva L.P., Tabagua T.T., Kazantseva M.D., Tergoeva A.P., Ulrikh D.G., Chervyak M.V., Klimenko V.V., Amirov N.S., Zhiltsova E.K., Semiglazov V.V.
Klinicheskiy sluchay uspeshnogo lecheniya erilibulinom metastaticheskogo raka molochnoy zhelezy
Limareva S.V., Laytsan K.Y., Stroyakovskiy D.L., Demidova I.A., Gorbunova V.A.
Perspektivy primeneniya kapsul vinorelbina v sovremennoy onkologii
Gutorov S.L., Stepanchenko M.V., Lichinitser M.R.
Experience of the use of ixabepilone in polychemotherapy regimens for disseminated triple-negative breast cancer
Glazkova E.V., Frolova M.A., Menshikov S.F., Stenina M.B.
Eribulin – novyy mikrotrubochkovyy ingibitor dlya lecheniya metastaticheskogo raka molochnoy zhelezy
Stenina M.B.
Algorithm for diagnostics and systemic therapy of metastatic hormone-sensitive HER2-negative breast cancer
Dashyan G.A., Olchonova A.A., Dzhelyalov E.S., Akhmedov R.M., Sereda O.A., Vats A.B., Zhurov A.S., Shaikhelislamova L.F., Pushkaruk G.A., Belousov A.M.
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Grechukhina K.S., Vorontsova K.A., Kuko T.M., Prosvirnov A.A., Ganshina I.P., Lubennikova E.V., Kolyadina I.V., Zhukova L.G.
PARP inhibitors in a personalized approach to the treatment of castration-resistant prostate cancer: clinical case
Gritskevich A.A., Byteman T.P., Monakov D.M., Rusakov I.G., Mishugin S.V.
The use of panitumumab in the treatment of chemoresistant metastatic sigmoid colon adenocarcinoma: a clinical case
Protsenko S.A., Teletaeva G.M., Degtyareva E.A., Semenova A.I., Latipova D.K., Novik A.V.
The use of ramukirumab in the treatment of metastatic gastric cancer in real clinical practice
Belyak N.P., Kutukova S.I., Orlova R.V., Zhukova N.V., Erdniev S.P., Zorina E.Y., Avramenko I.V., Antimonik N.Y., Popova N.V., Ivanova A.K., Androsova A.V.
Opyt primeneniya monoklonal'nykh antitel - blokatorov EGFR v lechenii metastaticheskogo kolorektal'nogo raka
Abramova N.A., Storozhakova A.E., Kalabanova E.A., Kabanov S.N., Popova I.L., Novoselova K.A., Tikhanovskaya N.M., Agieva A.A., Snezhko T.A., Samaneva N.Y., Kit O.I., Vladimirova L.Y.
Chemotherapy of anthracy-clineand taxan-resistant breast cancer
Kovalenko E.I., Satirova E.F., Artamonova E.V., Manzyuk L.V.
Potentials for the use of aflibercept in the treatment of patients with metastatic colorectal cancer
Vladimirova L.Y., Abramova N.A., Popova I.L., Storozhakova A.E., Novoselova K.A., Tikhanovskaya N.M., Ryadinskaya L.A., Lyanova A.A., Myagkova V.S., Teplyakova M.A., Kabanov S.N., Kalabanova E.A., Samaneva N.Y., Tishina A.V., Strakhova L.K., Yezhova M.O.
Efficacy and safety of therapy with biosimilar bevacizumab in the treatment of patients with metastatic colon cancer -a series of clinical observations
Fedyanin M.Y., Elsnukaeva K.K., Pokataev I.A., Sekhina O.V., Chekini D.A., Bulanov A.A., Tryakin A.A., Tyulyandin S.A.
SEARCH FOR MARKERS OF EFFICIENCY OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
Gutorov S.L., Borisova E.I., Chichikov E.I., Denisenko A.N., Borisova Y.I., Chichikov Y.I., Denisenko A.L., Gutorov S.L.
PROGNOSTIC SIGNIFICANCE OF THE E-CADHERIN EXPRESSION LEVEL IN PRIMARY TUMORS OF THE COLON IN PATIENTS WITH METASTATIC COLORECTAL CANCER, RECEIVED NEW CHEMOTHERAPY REGIMEN BASED ON TRIPLE COMBINATION: IRINOTECAN+OXALIPLATIN+CONTINUOUS-INFUSION 5-FLUOROURACIL AS A FIRST-LINE TREATMENT
Darenskaya A.D., Dobrova N.V., Khochenkov D.A., Stepanova E.V.
RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER"
Artamonova E.V., Bolotina L.V., Gligorov Z., Zhukov N.V., Zhukova L.G., Imyanitov E.N., Karabina E.V., Kovalenko E.I., Lichinitser M.R., Manzyuk L.V., Semiglazov V.F., Semiglazova T.Y., Stroyakovsky D.L.
XELODA IN THE TREATMENT OF METASTATIC COLORECTAL CANCER
Dobrova N.V., Dobrova N.V.
Will our clinical practice change with the availability of new diagnostic methods, drug therapy and assessment of its effectiveness? Clinical case: hormone receptor-positive, HER2-negative metastatic breast cancer
Konstantinova M.M., Kuzina L.I.
CLINICAL CASE OF SUCCESSFUL TREATMENT OF METASTATIC COLORECTAL CANCER WITH ACHIEVEMENT OF COMPLETE PATHOMORPHOLOGICAL RESPONSE (FIRST LINE CHEMOTHERAPY)
Darenskaya A.D., Dobrova N.V., Zhukova L.G., Medvedeva B.M., Mochalnikova V.V.
KOMPLEKSNAYa TERAPIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V.F., Semiglazov V.V., Nikolaev K.S., Dashyan G.A., Paltuev R.M.
Olaparib -modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
Lubennikova E.V., Zhukova L.G., Gordeeva O.O., Drobot N.T., Kuznetsov A.V., Ganshina I.P.
Oral chemotherapy with vinorelbine for advanced breast cancer: its role in clinical practice
Sakaeva D.D., Nasretdinov A.F.
CYCLIN-DEPENDENT KINASE INHIBITORS - NEW THERAPEUTIC OPTION FOR PATIENTS WITH HORMONE-DEPENDENT HER2-NEGATIVE BREAST CANCER: CLINICAL EXPERIENCE
Sakaev D.D., Iskhakova A.I., Kunafina R.I.
NOVYY REZhIM PERVOY LINII KhIMIOTERAPII METASTATIChESKOGO KOLOREKTAL'NOGO RAKA
Darenskaya A.D., Dobrova N.V.
Dynamics of indicators of systemic and local immunity during treatment in patients with gastric cancer
Khakimova G.G., Tryakin A.A., Zabotina T.N.
LONG-TERM RESULTS OF SECOND LINE ANTICANCER THERAPY OF METASTATIC COLORECTAL CANCER AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL CHARACTERISTICS
Vorontsova K.A., Chemoglazova E.V., Rotobelskaya L.E., Vyshinskaya G.V.
Palbociclib - new possibilities of therapy of hormon-positive HER2-negative breast cancer
Zhukova L.G., Chichikov E.I., Gordeeva O.O., Filonenko D.A.
Sovremennye vozmozhnosti lecheniya bol'nykh disseminirovannym kolorektal'nym rakom: II liniya lekarstvennoy terapii -
Vorontsova K.A., Dobrova N.V., Vyshinskaya G.V.
KONVERSIONNAYa I NEOAD\"YuVANTNAYa TERAPIYa PRI METASTAZAKh KOLOREKTAL'NOGO RAKA V PEChEN'
Sekacheva M.I.
A unique case of colon cancer metastasis treatment. A case from practice
Khakimova G.G., Islamov F.S., Khakimov G.A.
Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis
Vladimirova L.Y., Popova I.L., Abramova N.A., Storozhakova A.E., Tikhanovskaya N.M., Novoselova K.A., Lyanova A.A., Ryadinskaya L.A., Yezhova M.O., Teplyakov M.A.
NOVYE VOZMOZhNOSTI TERAPII BOL'NYKh METASTATIChESKIM RAKOM MOLOChNOY ZhELEZY, POLUChAVShIKh RANEE ANTRATsIKLINI TAKSAN-SODERZhAShchUYu KhIMIOTERAPIYu: OBZOR LITERATURY I KLINIChESKIY SLUChAY
Zhukova L.G.
1 - 36 of 36 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"